 Cubist Systematic Strategies LLC acquired a new stake in Cabaletta Bio NASDAQ:CABA during the fourth quarter, according to its most recent 13F filing with the SEC. The fund acquired 5,505 shares of the companys stock, valued at approximately 77,000. Other institutional investors have also recently made changes to their positions in the company. Victory Capital ... 